Benign Adipocytic Tumor | Most Common Soft Tissue Mass | Excellent Prognosis
Anatomical Classification
Critical Must-Knows
- Most common soft tissue tumor in adults (50% of all benign masses)
- Superficial lipomas rarely transform to sarcoma (less than 1%)
- Deep or rapidly growing lipomas require MRI to exclude liposarcoma
- Simple excision curative for superficial lesions; recurrence less than 5%
- Histology shows mature adipocytes without atypia or lipoblasts
Clinical Pearls
- "Deep lipomas have higher recurrence and require imaging to exclude malignancy
- "Atypical lipomatous tumor (ALT) is well-differentiated liposarcoma by another name
- "Multiple lipomas suggest familial lipomatosis or Madelung disease
- "Intramuscular lipomas infiltrate and have 20% recurrence after marginal excision
Clinical Imaging
Imaging Gallery
Critical Lipoma Exam Points
Benign vs Malignant Distinction
Deep location, size greater than 5cm, rapid growth are red flags for liposarcoma. MRI shows thick septations, nodularity, and contrast enhancement in malignant lesions.
Anatomical Classification
Superficial (subcutaneous), deep (subfascial), intramuscular - location determines recurrence risk and need for imaging. Deep lesions require MRI to rule out well-differentiated liposarcoma.
Histological Variants
Conventional, spindle cell, pleomorphic, hibernoma - most are conventional mature fat. Atypical features (lipoblasts, MDM2 amplification) indicate liposarcoma.
Treatment Algorithm
Observation vs simple excision - asymptomatic superficial lipomas can be observed. Symptomatic, deep, or atypical lesions require excision with marginal margins.
LARGELipoma Red Flags (Suspect Liposarcoma)
| L | Location deep Subfascial or intramuscular location |
| A | Age over 50 Liposarcoma more common in older adults |
| R | Rapidly growing Growth over weeks to months |
| G | Greater than 5cm Size cutoff for imaging workup |
| E | Enhancement on MRI Contrast uptake suggests malignancy |
| L | Location deep Subfascial or intramuscular location | G | Greater than 5cm Size cutoff for imaging workup |
| A | Age over 50 Liposarcoma more common in older adults | E | Enhancement on MRI Contrast uptake suggests malignancy |
| R | Rapidly growing Growth over weeks to months |
Hook:LARGE lipomas need imaging - think liposarcoma until proven otherwise!
FATTYMRI Features of Benign Lipoma
| F | Fat signal homogeneous Identical to subcutaneous fat on all sequences |
| A | All sequences suppress Complete suppression on fat-saturated images |
| T | Thin septations Septa less than 2mm thick if present |
| T | T1 hyperintense High signal on T1 (same as fat) |
| Y | Y no enhancement No contrast uptake on post-gadolinium sequences |
| F | Fat signal homogeneous Identical to subcutaneous fat on all sequences | T | T1 hyperintense High signal on T1 (same as fat) |
| A | All sequences suppress Complete suppression on fat-saturated images | Y | Y no enhancement No contrast uptake on post-gadolinium sequences |
| T | Thin septations Septa less than 2mm thick if present |
Hook:FATTY on MRI means benign - homogeneous fat signal with thin septa and no enhancement!
SIMPLESurgical Principles for Lipoma Excision
| S | Superficial needs simple excision Subcutaneous lipomas can be enucleated |
| I | Incision 50% of diameter Smaller incision possible due to lipoma compressibility |
| M | Margins not critical for benign Enucleation adequate if confirmed benign lipoma |
| P | Pseudocapsule guides dissection Clear plane exists between lipoma and normal fat |
| L | Large or deep needs imaging MRI before surgery for deep or atypical lesions |
| E | Excise completely to prevent recurrence Incomplete excision leads to 5-20% recurrence |
| S | Superficial needs simple excision Subcutaneous lipomas can be enucleated | M | Margins not critical for benign Enucleation adequate if confirmed benign lipoma | L | Large or deep needs imaging MRI before surgery for deep or atypical lesions |
| I | Incision 50% of diameter Smaller incision possible due to lipoma compressibility | P | Pseudocapsule guides dissection Clear plane exists between lipoma and normal fat | E | Excise completely to prevent recurrence Incomplete excision leads to 5-20% recurrence |
Hook:SIMPLE excision for superficial lipomas - enucleate along pseudocapsule for low recurrence!
Overview and Epidemiology
Lipomas are benign tumors of mature adipose tissue and represent the most common soft tissue neoplasm in adults. They are the largest single diagnostic category among benign soft tissue tumors (16% of an AFIP pathology archive of 18,677 benign lesions; up to roughly half of masses in some clinical referral series) and have an estimated incidence of about 1 per 1000 individuals. Most lipomas are solitary, slow-growing, and superficial (subcutaneous), presenting as soft, mobile masses that are asymptomatic.
Clinical Significance
Lipomas are the single most common reason for referral to soft tissue tumor clinics. The key clinical challenge is distinguishing benign lipoma from well-differentiated liposarcoma (atypical lipomatous tumor) in deep-seated lesions.
Demographics
- Age: Peak incidence 40-60 years
- Gender: Equal male and female distribution
- Location: 80% trunk and extremities
- Multiplicity: 5-10% have multiple lipomas
Risk Factors
- Familial lipomatosis: Autosomal dominant
- Madelung disease: Multiple symmetric lipomas, alcohol-related
- Gardner syndrome: Lipomas with colonic polyposis
- Proteus syndrome: Hamartomatous overgrowth
Pathophysiology and Anatomy
Anatomical Locations
Lipomas can arise in any location where adipose tissue is present. The distribution and behavior varies by anatomical site.
| Location | Frequency | Anatomical Considerations | Clinical Significance |
|---|---|---|---|
| Trunk (back, shoulders) | 40% | Subcutaneous fat layer, superficial | Easily accessible, low recurrence |
| Upper extremity | 25% | Superficial or within muscle compartments | Intramuscular type more common in thigh |
| Lower extremity | 20% | Thigh most common, often intramuscular | Higher recurrence for intramuscular type (20%) |
| Head and neck | 10% | Spindle cell variant common posteriorly | Cosmetically sensitive area |
| Retroperitoneum | Under 5% | Deep to abdominal cavity | High risk of being atypical lipomatous tumor |
Tissue Biology
Lipomas arise from mature adipocytes with clonal chromosomal abnormalities. Despite being benign, they represent true neoplasms rather than simply excess fat.
Origin
- Arise from mesenchymal adipocyte precursors
- Clonal chromosomal aberrations (12q13-15 in 60-70%)
- Encapsulated by thin fibrous pseudocapsule
- Distinct from normal adipose tissue (neoplastic)
Biomechanics
- Soft consistency allows compression through small incisions
- Pseudocapsule provides natural dissection plane
- Intramuscular type infiltrates between muscle fibers
- Deep lesions may compress adjacent neurovascular structures
Classification Systems
By Anatomical Location
| Type | Location | Characteristics | Recurrence Risk |
|---|---|---|---|
| Superficial (subcutaneous) | Above muscle fascia | 90% of lipomas, easily mobile, typical exam | Under 5% |
| Deep (subfascial) | Below fascia, not within muscle | May compress adjacent structures, MRI needed | 5-10% |
| Intramuscular (infiltrative) | Within muscle fibers | Infiltrates muscles, difficult complete excision | 15-20% |
| Intermuscular | Between muscle groups | May involve neurovascular bundles | 10-15% |
Classification by location determines the need for imaging, surgical approach, and expected recurrence risk.
Histology and Pathophysiology
Cellular Composition
Lipomas are composed of mature adipocytes identical to normal subcutaneous fat. The key histological feature is encapsulation by a thin fibrous pseudocapsule, allowing easy enucleation during surgery. Unlike normal fat, lipomas have clonal chromosomal aberrations (12q13-15 rearrangements in 60-70% of cases) indicating neoplastic origin.
Lipoma vs Liposarcoma Distinction
Critical histological differences:
- Lipoma: Mature adipocytes, no atypia, no lipoblasts
- Well-differentiated liposarcoma: Lipoblasts, nuclear atypia, MDM2/CDK4 amplification (FISH positive)
- Deep lipomas greater than 5cm should be biopsied or have MDM2 testing to exclude liposarcoma
Histological Variants
| Variant | Histological Features | Clinical Behavior | Treatment |
|---|---|---|---|
| Conventional lipoma | Mature adipocytes, thin capsule | Benign, less than 5% recurrence | Simple excision |
| Spindle cell lipoma | Fat with spindle cells and collagen | Benign, posterior neck/shoulder common | Simple excision |
| Pleomorphic lipoma | Bizarre nuclei (degenerative atypia) | Benign despite atypia, posterior neck | Excision, rule out liposarcoma |
| Intramuscular lipoma | Infiltrates muscle fibers | Higher recurrence (20%), thigh common | Wide excision |
| Hibernoma | Brown fat (multivacuolated cells) | Benign, highly vascular on imaging | Excision if symptomatic |
Clinical Assessment
History
Presenting Symptoms
- Painless mass: Most common presentation (80%)
- Cosmetic concern: Visible lump, especially facial/neck
- Mechanical symptoms: Compression of adjacent structures
- Duration: Usually years (slow growth)
Key Questions
- Rate of growth: Rapid growth concerning for sarcoma
- Pain: Lipomas typically painless; pain suggests angiolipoma or malignancy
- Family history: Multiple lipomas may be familial
- Trauma history: Some patients report preceding trauma (no causal link proven)
Physical Examination
Examination Sequence
Look for:
- Size and location of mass
- Skin changes (rarely present in lipomas)
- Multiple masses (familial lipomatosis)
Characteristic findings:
- Soft, doughy consistency
- Mobile (moves with skin, not muscle)
- Non-tender unless angiolipoma variant
- Lobulated surface
- Slip sign positive (slips under fingers)
Muscle contraction test:
- Superficial lipomas become more prominent with muscle relaxation
- Deep lipomas become less prominent or fixed with muscle contraction
- This simple test guides need for imaging
Examination Findings Suggesting Malignancy
Concerning features on examination:
- Fixed to deep structures
- Firm or hard consistency
- Rapid enlargement
- Size greater than 5cm
- Deep to fascia
- Associated neurovascular symptoms
These findings warrant MRI imaging to exclude liposarcoma.
Investigations
Imaging Protocol
Superficial (Subcutaneous) Approach
Indications for imaging:
- Size greater than 5cm
- Atypical examination findings
- Deep location suspected
Ultrasound (first-line for superficial lesions):
- Hyperechoic mass with fine internal echoes
- Parallel orientation
- Thin or absent capsule
- No internal vascularity on Doppler
Outcome: Most superficial lipomas under 5cm do not require imaging before excision.
Imaging Comparison: Lipoma vs Liposarcoma
| Feature | Benign Lipoma | Well-Differentiated Liposarcoma |
|---|---|---|
| Size | Usually under 5cm | Often greater than 10cm |
| MRI signal | Homogeneous fat signal | Heterogeneous with non-fat areas |
| Septations | Thin (under 2mm) or absent | Thick (over 2mm) nodular |
| Contrast enhancement | None | Present in non-fat components |
| Location | Superficial common | Deep (intramuscular, retroperitoneal) |
Histological Diagnosis
Biopsy indications:
- Deep lipoma with atypical imaging features
- Size greater than 5cm with thick septations
- Clinical suspicion of malignancy
Biopsy technique:
- Core needle biopsy (14-16 gauge) adequate for most cases
- MDM2 amplification testing distinguishes atypical lipomatous tumor from lipoma
- Excisional biopsy for small superficial lesions
Imaging: Unusual Locations
Deep lipomas can occur in unexpected locations such as the hand, causing compression symptoms.
Management
Treatment Algorithm
Treatment Decision Matrix
| Clinical Scenario | Management | Rationale | Follow-up |
|---|---|---|---|
| Small (under 5cm), superficial, asymptomatic | Observation | Benign natural history, no malignant potential | Annual clinical exam or as needed |
| Superficial, symptomatic (cosmetic/discomfort) | Simple excision | Curative with low recurrence (under 5%) | No routine follow-up needed |
| Deep or size greater than 5cm | MRI then excision | Rule out liposarcoma before surgery | Histology confirmation, recurrence monitoring |
| Atypical imaging (thick septa, enhancement) | Biopsy then wide excision | Liposarcoma likely, need margin clearance | MDT discussion, oncology referral |
Conservative Management
Indications for observation:
- Asymptomatic superficial lipoma
- Small size (under 5cm)
- Stable over time
- Patient preference
Monitoring protocol:
- Annual clinical examination
- Patient education on red flag symptoms (rapid growth, pain)
- Repeat imaging not routinely required unless symptoms change
Surgical Management
Superficial Lipoma Excision
Indications:
- Symptomatic lipoma (pain, cosmetic concern)
- Superficial location
- Size typically under 5cm
Technique:
Surgical Steps
- Directly over the mass or along skin tension lines
- Incision length approximately 50% of tumor diameter
- Dissect to tumor pseudocapsule
- Blunt dissection along capsule plane
- Tumor usually shells out easily
- Minimal bleeding due to avascular plane
- Check for complete excision
- Minimal dead space (lipomas compress)
- Subcuticular closure for cosmesis
Outcomes:
- Recurrence rate less than 5%
- Same-day discharge
- Return to activities within 1-2 weeks
Simple excision remains the treatment of choice for symptomatic superficial lipomas.
Special Considerations
Multiple Lipomas
Familial lipomatosis or syndromic:
- Excise symptomatic lesions only
- Genetic counseling if autosomal dominant pattern
- Screen for associated conditions (Gardner syndrome)
Infiltrative Lipomas
Higher recurrence risk:
- Intramuscular and intermuscular types
- Wide excision preferred over enucleation
- Counsel about 20% recurrence despite surgery
Surgical Technique
Superficial Lipoma Excision - Step by Step
Standard Excision Protocol
Position based on lesion location:
- Limb lesions: supine with arm/leg extended
- Back lesions: prone or lateral decubitus
- Ensure adequate lighting and access
Local anesthesia (1% lidocaine with adrenaline):
- Infiltrate around lipoma circumferentially
- Field block for larger lesions
- General anesthesia rarely needed (deep lesions only)
Direct incision over maximum prominence:
- Length approximately 50% of tumor diameter (lipomas compress)
- Follow skin tension lines where possible
- Incise through skin and subcutaneous tissue to capsule
Blunt dissection along pseudocapsule:
- Use finger or blunt instrument
- Lipoma shells out with minimal bleeding
- Maintain capsule integrity (reduces spillage)
- Rarely need sharp dissection
Inspect cavity, achieve hemostasis:
- Minimal dead space naturally (cavity collapses)
- Drain not required for superficial lesions
- Close subcutaneous tissue with absorbable sutures
- Subcuticular or interrupted skin closure
Deep Lipoma Technique Pearls
Approach Considerations
- Pre-operative MRI mandatory to plan approach
- Identify neurovascular structures before incision
- Consider tourniquet for limb lesions
- Wider exposure than superficial excision
Technical Tips
- Aim for 1-2cm margins if liposarcoma possible
- Careful nerve dissection under loupe magnification
- Place drain for large dead space
- Send specimen oriented for margin assessment
Postoperative Care
Standard Recovery Protocol
Postoperative Timeline
Wound care:
- Pressure dressing for 24-48 hours
- Ice application to reduce swelling
- Standard analgesia (paracetamol ± NSAID)
- Limb elevation if applicable
Activity:
- Light activities permitted immediately
- Avoid heavy lifting or stretching wound
- Keep wound dry for 48 hours
- Shower after 48 hours, no baths for 2 weeks
Follow-up:
- Suture removal at 7-14 days (location dependent)
- Check for seroma, hematoma, infection
- Histology results review
- Counsel on prognosis based on final pathology
Return to activities:
- Full activities by 2-4 weeks for superficial
- Sports and heavy work at 4-6 weeks
- Scar massage to optimize cosmesis
- No further follow-up needed if benign confirmed
Specific Considerations
| Scenario | Postoperative Modification | Rationale |
|---|---|---|
| Large lipoma (over 5cm) | Consider drain for 24-48 hours | Reduce seroma risk |
| Intramuscular lipoma | Restrict activity for 4 weeks, physio referral | Muscle healing, prevent hematoma |
| Deep lipoma near neurovascular bundle | Document neurovascular status postoperatively | Medicolegal protection, early detection of deficit |
| Histology shows atypical features | MDT referral, possible re-excision | Atypical lipomatous tumor needs wider margins |
Postoperative complications are infrequent after superficial lipoma excision but monitoring for seroma and infection should be routine.
Complications
Intraoperative Complications
| Complication | Incidence | Prevention | Management |
|---|---|---|---|
| Bleeding | Rare (under 1%) | Hemostasis during dissection | Direct pressure, cautery, rarely requires intervention |
| Nerve injury | 1-2% (higher for deep lipomas) | Identify nerves preoperatively (MRI), careful dissection | Nerve exploration if deficit, neurolysis vs repair |
| Incomplete excision | 5-10% (intramuscular type) | Wide dissection for infiltrative lesions | Re-excision if symptomatic recurrence |
Postoperative Complications
| Complication | Incidence | Risk Factors | Management |
|---|---|---|---|
| Seroma | 5-10% | Large dead space, inadequate compression | Aspiration, compression dressing, rarely requires drainage |
| Infection | Under 2% | Poor sterility, diabetes, immunosuppression | Antibiotics, drainage if abscess forms |
| Recurrence | Under 5% superficial; 15-20% intramuscular | Incomplete excision, infiltrative type | Re-excision with wider margins |
| Scar dissatisfaction | Variable | Location, patient factors, surgical technique | Scar revision if significant cosmetic concern |
Prognosis and Outcomes
Outcome by Location
| Location Type | Recurrence Rate | Complications | Prognosis |
|---|---|---|---|
| Superficial subcutaneous | Under 5% | Minimal; seroma, scar | Excellent; curative with simple excision |
| Deep subfascial | 5-10% | Nerve injury risk 1-2% | Excellent if benign confirmed; watch for liposarcoma |
| Intramuscular infiltrative | 15-20% | Higher nerve injury, incomplete excision | Good but recurrence common; wide excision recommended |
Prognostic Factors
Predictors of Recurrence
Factors associated with higher recurrence:
- Intramuscular or infiltrative subtype
- Incomplete excision (marginal excision for infiltrative lesions)
- Size greater than 10cm
- Deep location with complex anatomy
Superficial lipomas have excellent prognosis with simple excision and recurrence under 5%.
Evidence Base and Key Studies
Distribution of Benign Soft-Tissue Tumours (AFIP Referral Series)
- 18,677 benign mesenchymal lesions from a 10-year AFIP consultation archive
- Lipoma and lipoma variants were the single most common diagnostic category (16%)
- Roughly two-thirds of benign soft-tissue tumours fall into seven diagnostic groups
- Prevalence varies markedly with patient age and anatomical location
MRI of 126 Consecutive Fatty Masses: Lipoma vs Well-Differentiated Liposarcoma
- MRI was 100% sensitive and 100% NPV for detecting well-differentiated liposarcoma
- MRI was 100% specific for the diagnosis of simple lipoma
- But positive predictive value was only 38% — most 'suspicious' masses were benign
- 64% of lesions called suspicious for liposarcoma were actually benign lipoma variants
Controversies and Areas of Uncertainty
When can MRI alone be trusted?
A confidently benign MRI (homogeneous fat, thin septa, no enhancement) has high negative predictive value, but reader accuracy against MDM2/FISH is only about 73% for indeterminate deep masses. Practice varies on whether an "indeterminate" deep fatty mass should go straight to biopsy or to a sarcoma centre for re-imaging.
ALT vs well-differentiated liposarcoma terminology
"Atypical lipomatous tumour" and "well-differentiated liposarcoma" are the same MDM2-amplified entity; the benign-sounding ALT label is preferred for resectable extremity/trunk lesions, while WDL is used for retroperitoneal disease that cannot be widely excised and carries dedifferentiation risk.
Margin width for deep ALT
Marginal excision yields roughly 23% recurrence versus 0% for wide resection in extremity ALT, but routine wide resection adds morbidity. The threshold for accepting a planned marginal margin (e.g. near nerves) remains debated and is individualised at MDT.
Non-surgical and minimally invasive options
Liposuction, steroid injection and laser-assisted removal are described for selected superficial cosmetic lipomas, but evidence is limited, recurrence is higher, and no tissue margin or histology is obtained — so they are not used where liposarcoma cannot be excluded.
Exam Viva Scenarios
Use these scenarios to practise clinical reasoning and management decisions
Scenario 1: Superficial Lipoma Evaluation
"A 45-year-old woman presents with a 3cm soft, mobile mass on her upper arm that has been present for 2 years. She is concerned about the cosmetic appearance. On examination, you find a non-tender, doughy mass that slips under your fingers and becomes more prominent when she relaxes her arm. What is your assessment and management?"
Scenario 2: Deep Lipoma with Atypical Features
"A 55-year-old man presents with a 7cm mass in his thigh that has grown over the past 6 months. MRI shows a predominantly fatty mass with some thick septations and small areas of enhancement. What are your concerns and how would you proceed?"
Scenario 3: Multiple Lipomas
"A 35-year-old man presents with approximately 15 lipomas scattered over his trunk and arms. He has a family history of similar findings in his father. Several are becoming painful. How would you assess and manage this patient?"
MCQ Practice Points
Histology Question
Q: What is the key histological feature that distinguishes lipoma from well-differentiated liposarcoma? A: MDM2 amplification - Well-differentiated liposarcoma (atypical lipomatous tumor) shows MDM2 and CDK4 amplification on FISH testing, while lipoma does not. Histologically, lipoma shows mature adipocytes without lipoblasts or significant atypia. Lipoblasts and atypical stromal cells suggest liposarcoma.
Imaging Question
Q: What MRI features suggest liposarcoma rather than benign lipoma? A: Thick septations (greater than 2mm), nodular enhancement, heterogeneous signal - Benign lipomas show homogeneous fat signal identical to subcutaneous fat, with thin (less than 2mm) or no septa, and no contrast enhancement. Liposarcomas have thick irregular septa, non-fat soft tissue components, and enhancement.
Management Question
Q: What is the recurrence rate after simple excision of intramuscular lipoma? A: 15-20% - Intramuscular lipomas have infiltrative growth and significantly higher recurrence than superficial lipomas (under 5%). Wide excision is preferred when feasible, but infiltrative nature makes complete removal difficult. Superficial lipomas have excellent prognosis with simple enucleation.
Clinical Presentation Question
Q: What is the most common soft tissue tumor in adults? A: Lipoma - Lipomas account for approximately 50% of all benign soft tissue tumors. They are slow-growing, usually superficial, and present as soft mobile masses. Peak incidence is in the 5th-6th decade with equal gender distribution.
Red Flag Question
Q: What size cutoff prompts imaging for a clinically suspected lipoma? A: Greater than 5cm - Superficial lipomas under 5cm with typical examination findings do not require imaging. Lesions greater than 5cm, deep location, rapid growth, or atypical features warrant MRI to exclude liposarcoma before excision.
Guidelines, Registries & Global Practice
Global Epidemiology
Lipoma is the most common soft tissue tumour worldwide, with an estimated incidence of about 1 per 1000 population per year and no consistent geographic or ethnic predilection. Peak presentation is in the 4th to 6th decades with roughly equal sex distribution; about 5-10% of patients have multiple lesions. Atypical lipomatous tumour / well-differentiated liposarcoma is far rarer (a fraction of the roughly 5 soft tissue sarcomas per 100,000/year) and is concentrated in older adults with deep extremity or retroperitoneal masses.
Society Guidance, Side by Side
How Major Bodies Frame Fatty-Mass Workup
| Body (region) | Imaging threshold | Referral / diagnosis emphasis |
|---|---|---|
| NICE / sarcoma referral (UK) | Any deep soft-tissue mass, or superficial mass over ~5cm, growing or painful → urgent imaging | Refer indeterminate fatty masses to a sarcoma diagnostic pathway before excision |
| ESMO–EURACAN (Europe) | MRI for any deep or large (over 5cm) soft-tissue mass | Biopsy and management of suspected ALT/sarcoma at a reference sarcoma centre; MDM2 testing for ambiguous cases |
| NCCN (US) | Cross-sectional imaging (MRI) for indeterminate or deep lesions | Core-needle biopsy and multidisciplinary planning before resection of indeterminate fatty tumours |
| WHO Classification of Tumours (global) | Not an imaging guideline — defines pathology | ALT and well-differentiated liposarcoma are one MDM2-amplified entity; terminology depends on site/resectability |
Across bodies the consensus is consistent: a small, superficial, clinically typical lipoma needs neither imaging nor referral, while a deep or large (over 5cm) or growing fatty mass should be imaged and, if indeterminate, biopsied — ideally within a sarcoma service — before any excision. Differences are mainly in pathway structure (centralised sarcoma units in the UK/Europe vs more variable referral in some systems) rather than the underlying clinical logic. There is no dedicated implant or device registry for lipoma, as management is excisional rather than implant-based.
High- vs Limited-Resource Practice
Well-Resourced Settings
- MRI readily available for deep or large lesions
- MDM2 amplification (FISH or equivalent) to confirm ALT/WDL
- Sarcoma multidisciplinary teams direct biopsy-first management
Limited-Resource Settings
- Ultrasound may be the only modality; reliance on clinical red flags
- Histology available but molecular MDM2 testing often not
- Lower threshold for excisional biopsy of accessible lesions; refer deep/retroperitoneal masses where possible
Consent and Documentation
- Key risks to consent for: recurrence (under 5% superficial, 15-20% infiltrative intramuscular), nerve injury (1-2% for deep lesions), seroma, scar
- Alternatives: observation versus excision; confirm whether the indication is cosmetic or symptomatic
- Pathology: explain that all excised tissue is sent for histology to confirm the benign diagnosis
Medicolegal Considerations
Key documentation requirements:
- Document examination findings including depth assessment (muscle contraction test)
- Clear indication for imaging (size, location, atypical features)
- Informed consent discussing recurrence risk (varies by location)
- If liposarcoma suspected, document referral to sarcoma MDT
Common litigation issues:
- Failure to investigate deep or large lipomas with imaging (missed liposarcoma)
- Inadequate excision leading to recurrence
- Nerve injury during excision of deep lipomas without documentation of preoperative nerve status
LIPOMA
Clinical summary
Key Epidemiology
- •Most common soft tissue tumor (50% of all benign masses)
- •Incidence 1:1000 in population
- •Peak age 40-60 years, equal gender distribution
- •5-10% are deep (subfascial or intramuscular)
Classification
- •Superficial (subcutaneous) = 90% = simple excision
- •Deep (subfascial) = higher recurrence = need MRI
- •Intramuscular infiltrative = 15-20% recurrence = wide excision
- •Variants: spindle cell, pleomorphic (benign despite atypia), angiolipoma (painful)
Red Flags (LARGE Mnemonic)
- •Location deep (subfascial/intramuscular)
- •Age over 50 (liposarcoma more common)
- •Rapidly growing (weeks to months)
- •Greater than 5cm (imaging mandatory)
- •Enhancement on MRI (suggests malignancy)
Imaging Pearls
- •Superficial under 5cm with typical exam = no imaging needed
- •MRI mandatory for deep lipomas (rule out liposarcoma)
- •Benign features: homogeneous fat signal, thin septa (under 2mm), no enhancement
- •Malignant features: thick septa, nodularity, enhancement, heterogeneous signal
Surgical Principles (SIMPLE Mnemonic)
- •Superficial = simple excision (enucleation)
- •Intramuscular = wide excision preferred
- •Margins not critical if confirmed benign
- •Pseudocapsule provides dissection plane
- •Large/deep needs MRI first
Complications and Outcomes
- •Superficial recurrence under 5%, intramuscular 15-20%
- •Nerve injury 1-2% for deep lipomas
- •Seroma 5-10%, usually managed conservatively
- •Malignant transformation less than 1% (extremely rare)